SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Technical Chemical & Products (TCPI) -- Ignore unavailable to you. Want to Upgrade?


To: Brander who wrote (72)2/14/1998 4:30:00 PM
From: Vic  Read Replies (1) | Respond to of 111
 
I have done a lot of research into this company to know that this is a winner (you can look up some of my previous posts) and I am buying more shares at these prices. I have no Idea who Clemenza is but I do know that He or She does NOT know what they are talking about.



To: Brander who wrote (72)2/15/1998 5:29:00 PM
From: James Abraham  Read Replies (1) | Respond to of 111
 
My understanding is that SK pulled out because TCPI did not fit into its strategic plan afters its merger. Reliable source informs me that other drug companies are calling for the marketing rights. This source has always provided stock picks that have proved themselves.



To: Brander who wrote (72)2/18/1998 12:32:00 PM
From: Brad White  Read Replies (1) | Respond to of 111
 
Hi Brian. I am a pharmacist and know that if the non-invasive technology is even remotely affordable the company will be a blockbuster. I heard information through a guy that supposedly knows an engineer at TCPI that they are in Phase 3 trials with the FDA.
Know anything about that?
Brad